Enzyme inhibitors as drug substances. Part III;ENZYMINHIBITOREN ALS ARZNEISTOFFE. (TEIL III)

Pharmazie in Unserer Zeit

Volumn 27, Issue 1, 1998, Pages 12-17

  Nuhn, Peter ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; ENZYME INHIBITOR; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE INHIBITOR;

ARTICLE; BIOSYNTHESIS; HUMAN; INFLAMMATION;

ANIMALS; ENZYME INHIBITORS; HUMANS;

EID: 0031884653     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.19980270105     Document Type: Article

References (12)

1. Müller, M.J.: Der Leukotriensignalweg - ein vielversprechender Ansatzpunkt für Inhibitoren in der Therapie entzündlicher Erkrankungen. Pharm. uns. Zeit 24, (1995), 264.
2. 2. FASEB J. 8, (1994), 916-924.
3. Baumgärtner, M.: COX-2-selektive Antirheu-matika - ein Durchbruch? DAZ 137, (1997), 2157-2159.
4. Ullrich, V.; Brugger, R.: Prostacyclin-und Thromboxan-Synthase, neue Aspekte der Katalyse durch Hämthiolat-Enzyme. Angew. Chem. 106, (1994), 1987-1996.
5. Batt, D.G.: 5-Lipoxygenase inhibitors and their anti-inflammatory activities. Prog. Med. Chem. 29, (1992), 1-63.
6. Ford-Hutchinson, A.W.: FLAP: a novel drug target for inhibiting the synthesis of leukotrienes. TiPS 12, (1991), 68-70.
7. Tapparelli, C.; Metternich, R.; Ehrhart, C.; Cook, N.S.: Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile. TiPS 14, (1993), 366-369.
8. Beckett, R.P.; Davidson, A.H.; Drummond, A.H.; Huxley, P.; Whittaker, M.: Recent advances in matrix metalloproteinase inhibitor research. DDT 1, (1996), 16-26.
9. Dräger, B.: Glykosidasehemmstoffe. DAZ 136 (1996), 1199-1206.
10. Robinson, K.M.; Rhinehart, B.L.; Ducep, J.-B.; Danzin, C.: Intestinal disaccharide inhibitors. Drugs Fut. 17, (1992), 705-720.
11. Oates, P.J.: Aldose reductase inhibitors: Recent developments. Prog. Drug. Res. 40, (1993), 99-162.
12. Tomlinson, D.R.; Stevens, E.J.; Diemel, L.T.: Aldose reductase inhibitors an their potential for the treatment of diabetic complications. TiPS 15, (1994), 293-297.